PMDA drug package insert
アブストラル舌下錠100μg
PMDA Prescription drug · 協和キリン株式会社 · package insert Jan 15, 2025
Key facts
| Brand names | アブストラル舌下錠100μg, アブストラル舌下錠200μg, アブストラル舌下錠400μg |
|---|---|
| Nonproprietary names | フェンタニルクエン酸塩 |
| Companies | 製造販売元／協和キリン株式会社, 発売元／久光製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | がん疼痛治療剤 |
| Therapeutic category codes | 878219 |
| YJ codes | 8219001F1020, 8219001F2026, 8219001F3022 |
| Approval numbers | 22500AMX01804, 22500AMX01805, 22500AMX01806 |
| Package insert edition | 第3版 |
| Package insert date | Jan 15, 2025 |
| PMDA document key | 230124_8219001F1020_1 |
| PMDA company code | 230124 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: